Should Angiotensin Receptor Neprilysin Inhibitors Replace Angiotensin-converting Enzyme Inhibitors in Heart Failure With a Reduced Ejection Fraction?

Angiotensin-converting enzyme inhibitors (ACEIs) have been the cornerstone of treatment of heart failure with reduced ejection fraction (HFrEF) for over two decades. Inhibition of neprilyisin augments vasoactive substances including natriuretic peptides, which may have multiple advantageous effects...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Card Fail Rev
Autori principali: Hayman, Sam, Atherton, John J
Natura: Artigo
Lingua:Inglês
Pubblicazione: Radcliffe Cardiology 2016
Soggetti:
Pharmacological Therapy
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5490929/
https://ncbi.nlm.nih.gov/pubmed/28785452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15420/cfr.2016:2:2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi